Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bio Blast Pharma Ltd.

www.bioblast-pharma.com

Latest From Bio Blast Pharma Ltd.

How To Get 270 Approvals At Once? – Stealth's Rare Disease Strategy

With FDA’s blessing, Stealth BioTherapeutics is working toward a pivotal trial that would address an underlying cause, mitochondrial myopathy, of roughly 270 very rare diseases, potentially leading to an aggregate approval in all of those unmet medical needs.

BioPharmaceutical United States

Start-Up Execs On The Move, March 2015

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

BioPharmaceutical Medical Device

Execs On The Move, March 2015

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device

Biopharma In 2014: Early Access Gains Offset Taxation, Pricing Woes

The year was marked by record levels of biopharma M&A activity and a strong IPO market. Measures designed to deliver early access to new medicines continued to advance on both sides of the Atlantic, while pricing came in for renewed attention as new, highly effective but extremely expensive products reached the market.

BioPharmaceutical Pricing Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Bio Blast Pharma Ltd.
  • Senior Management
  • Colin Foster, Pres. & CEO
    Robert W Cook, CFO
    Warren Wasiewski, MD, CMO, VP R&D
    Paul Firuta, Chief Commercial Officer
    Theresa M Stevens, Chief Corp Dev Officer
    Leigh Cherry, VP, Mfg
  • Contact Info
  • Bio Blast Pharma Ltd.
    Phone: 7 2240 9060
    37 Dereh Menachem Begin St.
    15th Floor
    Tel Aviv, 6522042
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register